Angiodynamics Inc SEC filings ANGO
Angiodynamics Inc has 1,002 filings in SEC EDGAR's recent list, going back to Aug 24, 2011. Its latest annual report, Form 10-K, was filed on Jul 14, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 8, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Oct 8, 2026 | — |
| DEF 14A | Proxy statement | Oct 8, 2026 | Nov 17, 2026 |
| DEFA14A | Additional proxy material | Sep 25, 2025 | — |
| DEF 14A | Proxy statement | Sep 25, 2025 | May 31, 2025 |
| DEFA14A | Additional proxy material | Sep 26, 2024 | — |
| DEF 14A | Proxy statement | Sep 26, 2024 | May 31, 2024 |
| DEFA14A | Additional proxy material | Nov 7, 2023 | — |
| DEFA14A | Additional proxy material | Sep 28, 2023 | — |
| DEF 14A | Proxy statement | Sep 28, 2023 | May 31, 2023 |
| DEFA14A | Additional proxy material | Oct 12, 2022 | — |
| DEFA14A | Additional proxy material | Sep 22, 2022 | — |
| DEF 14A | Proxy statement | Sep 22, 2022 | May 31, 2022 |
| DEFA14A | Additional proxy material | Sep 22, 2021 | — |
| DEF 14A | Proxy statement | Sep 22, 2021 | May 31, 2021 |
| DEFA14A | Additional proxy material | Sep 3, 2020 | — |
| DEF 14A | Proxy statement | Sep 3, 2020 | May 31, 2020 |
| DEFA14A | Additional proxy material | Sep 5, 2019 | — |
| DEF 14A | Proxy statement | Sep 5, 2019 | May 31, 2019 |
| DEFA14A | Additional proxy material | Aug 30, 2018 | — |
| DEF 14A | Proxy statement | Aug 30, 2018 | May 31, 2018 |
| DEFA14A | Additional proxy material | Sep 7, 2017 | — |
| DEF 14A | Proxy statement | Sep 7, 2017 | Oct 17, 2017 |
| DEFA14A | Additional proxy material | Sep 15, 2016 | — |
| DEF 14A | Proxy statement | Sep 15, 2016 | Oct 25, 2016 |
| DEFA14A | Additional proxy material | Sep 17, 2015 | — |
| DEF 14A | Proxy statement | Sep 17, 2015 | Oct 27, 2015 |
| DEFA14A | Additional proxy material | Sep 17, 2014 | — |
| DEF 14A | Proxy statement | Sep 17, 2014 | Oct 28, 2014 |
| PRE 14A | Preliminary proxy statement | Aug 29, 2014 | Oct 28, 2014 |
| DEFA14A | Additional proxy material | Sep 11, 2013 | — |
| DEF 14A | Proxy statement | Sep 11, 2013 | Oct 22, 2013 |
| DEFA14A | Additional proxy material | Sep 10, 2012 | — |
| DEFA14A | Additional proxy material | Sep 10, 2012 | — |
| DEF 14A | Proxy statement | Sep 10, 2012 | Oct 22, 2012 |
| DEFA14A | Additional proxy material | Apr 18, 2012 | — |
| DEFM14A | Definitive proxy statement | Apr 2, 2012 | — |
| PREM14A | Preliminary proxy statement | Feb 28, 2012 | May 29, 2012 |
| DEFA14A | Additional proxy material | Feb 23, 2012 | — |
| DEFA14A | Additional proxy material | Feb 7, 2012 | — |
| DEFA14A | Additional proxy material | Feb 3, 2012 | — |
| DEFA14A | Additional proxy material | Feb 1, 2012 | — |
| DEFA14A | Additional proxy material | Jan 31, 2012 | — |
| DEFA14A | Additional proxy material | Sep 6, 2011 | — |
| DEF 14A | Proxy statement | Sep 6, 2011 | Oct 17, 2011 |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ANGO (Nasdaq)
- Fiscal year ends
- May 31
- Incorporated in
- DE
- Headquarters
- Latham, NY
- SEC filer status
- Accelerated filer
- SEC CIK
- 1275187
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.